Let's Chat About...LCA Community Survey Results
Join our conversation on LCA Community Survey Results with Kathleen Hayes
Let’s Chat About … LCA Community Survey Results
Join our Zoom with Kathleen Hayes, MPH, Senior Account Manager at SmithSolve LLC, an agency specializing in rare disease communication. Kathleen will be discussing the results of the LCA community survey that was distributed in April and May.
About Kathleen Hayes
Kathleen brings over a decade of public health experience, drawing on a rich background in federal government, healthcare, and non-profit organizations. Her diverse background allows her to bring a unique perspective to health communications and cultivate enduring relationships with internal and external stakeholders.
Kathleen translates complex science into stories and messages that can be easily understood by patients, advocates, the public, and other audiences. Her project management and forward-thinking strategic planning skills earned her a reputation of doing hard things well.
Prior to joining SmithSolve, Kathleen worked at the U.S. Food and Drug Administration (FDA) as a Designated Federal Officer (DFO) managing two high-profile advisory committees. This work involved adhering with regulatory directives and communicating appropriate information to the public to maintain transparency and support education.
Before her tenure at FDA, she worked as a health scientist at the Centers for Disease Control and Prevention (CDC). In her roles in the Office of Science and in the National Center for Emerging and Zoonotic Infectious Diseases, she coordinated and managed data quality initiatives and helped to bring the latest technologies to address public health needs across the CDC. She organized and executed a variety of health communication activities, developed communication materials, and disseminated communication tools and public health messages to multiple audiences.
Kathleen earned a Master of Public Health (MPH) in international health and a B.S. in Human Development from Oregon State University.
About the "Let's Chat About..." Web Series
This webinar is part of our continued Let’s Chat About webinar series. We've developed this free, virtual web series with those living with LCA and IRDs in mind, but we invite all members of our community, including those in research, industry, and the regulatory communities to join any of the sessions, as we look ahead to a common goal of advancing treatments for rare retinal disease.